Oliver Waidmann

7.7k total citations · 1 hit paper
116 papers, 4.1k citations indexed

About

Oliver Waidmann is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Oliver Waidmann has authored 116 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hepatology, 38 papers in Oncology and 35 papers in Epidemiology. Recurrent topics in Oliver Waidmann's work include Liver Disease Diagnosis and Treatment (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers) and Hepatitis C virus research (15 papers). Oliver Waidmann is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers) and Hepatitis C virus research (15 papers). Oliver Waidmann collaborates with scholars based in Germany, Switzerland and Australia. Oliver Waidmann's co-authors include Stefan Zeuzem, Bernd Kronenberger, Albrecht Piiper, Fabian Finkelmeier, Jörg Trojan, Jelena Korać-Prlić, Volker Dötsch, Verena Köberle, Ivan Đikić and Thomas Pleli and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Oliver Waidmann

106 papers receiving 4.0k citations

Hit Papers

Phosphorylation of the Autophagy Receptor Optineurin Rest... 2011 2026 2016 2021 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth
    2011 1.0k citations Philipp S. Wild, Hesso Farhan et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Waidmann Germany 32 1.7k 1.6k 1.0k 848 698 116 4.1k
Hua Huang China 29 1.3k 0.8× 783 0.5× 658 0.7× 794 0.9× 662 0.9× 144 3.3k
Bernd Kronenberger Germany 35 1.3k 0.8× 1.3k 0.9× 904 0.9× 1.4k 1.6× 403 0.6× 104 3.4k
Zsuzsa Schaff Hungary 34 1.1k 0.7× 805 0.5× 604 0.6× 575 0.7× 619 0.9× 154 3.4k
Ilona Kovalszky Hungary 40 2.1k 1.3× 703 0.4× 1.0k 1.0× 413 0.5× 932 1.3× 182 4.8k
Salvatore Antonaci Italy 37 1.8k 1.1× 690 0.4× 893 0.9× 1.0k 1.2× 1.1k 1.6× 189 4.4k
Bruno Sáinz Spain 39 2.0k 1.2× 1.1k 0.7× 1.1k 1.1× 620 0.7× 1.7k 2.4× 88 4.7k
Takuya Miyagi Japan 34 1.3k 0.8× 1.0k 0.7× 427 0.4× 825 1.0× 774 1.1× 104 4.0k
Gary Reynolds United Kingdom 45 1.3k 0.8× 1.7k 1.1× 436 0.4× 1.7k 2.0× 1.2k 1.8× 94 5.4k
Ingmar Mederacke Germany 23 1.2k 0.7× 2.7k 1.7× 317 0.3× 2.6k 3.1× 514 0.7× 46 4.6k
Hitoshi Asakura Japan 41 1.4k 0.9× 1.7k 1.1× 384 0.4× 1.4k 1.6× 913 1.3× 187 5.7k

Countries citing papers authored by Oliver Waidmann

Since Specialization
Citations

This map shows the geographic impact of Oliver Waidmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Waidmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Waidmann more than expected).

Fields of papers citing papers by Oliver Waidmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Waidmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Waidmann. The network helps show where Oliver Waidmann may publish in the future.

Co-authorship network of co-authors of Oliver Waidmann

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Waidmann. A scholar is included among the top collaborators of Oliver Waidmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Waidmann. Oliver Waidmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Himmelsbach, Vera, Bernhard Scheiner, Matthias Pinter, et al.. (2024). Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Cancers. 16(13). 2442–2442. 3 indexed citations
2.
3.
Fischer, Janett, Tobias Müller, R Heyne, et al.. (2023). Sex‐differences in the association of interleukin‐10 and interleukin‐12 variants with the progression of hepatitis B virus infection in Caucasians. Hepatology Research. 53(12). 1156–1168.
4.
5.
Fischer, Janett, Tobias Müller, R Heyne, et al.. (2022). Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens. 12(1). 54–54. 5 indexed citations
6.
Himmelsbach, Vera, Matthias Pinter, Bernhard Scheiner, et al.. (2022). Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers. Cancers. 14(7). 1722–1722. 34 indexed citations
7.
Queck, Alexander, Christine Koch, Dirk Walter, et al.. (2021). Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study. Oncology Research and Treatment. 45(3). 79–87. 5 indexed citations
8.
9.
Juratli, Mazen A., Ümniye Balaban, Hanan El Youzouri, et al.. (2020). Einführung eines interdisziplinären Tumorboards führt zur Verbesserung der Behandlungsergebnisse von Cholangio- und Gallenblasenkarzinomen. Der Chirurg. 91(8). 650–661. 2 indexed citations
10.
Kubesch, Alica, Oliver Waidmann, Irina Blumenstein, et al.. (2020). A Single-Center Case Series of Endoscopically Treated Aorto-Gastrointestinal Fistula after Endovascular Aortic Repair: Surgery Is Still the Only Valid Solution. Visceral Medicine. 37(2). 134–141. 2 indexed citations
11.
Walter, Dirk, Patrick N. Harter, Florian Battke, et al.. (2018). Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors. Scientific Reports. 8(1). 3811–3811. 37 indexed citations
12.
Koch, Christine, Ria Winkelmann, Katrin Eichler, et al.. (2018). Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates. Digestion. 98(4). 263–269. 2 indexed citations
13.
Ibrahim, Ahmed Atef, Christian Schmithals, Verena Köberle, et al.. (2017). Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial–Mesenchymal Transition. Clinical Cancer Research. 23(14). 3896–3905. 31 indexed citations
14.
Finkelmeier, Fabian, Özge Canli, Andrea O. Tal, et al.. (2016). High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. European Journal of Cancer. 59. 152–159. 171 indexed citations
15.
Schmithals, Christian, Verena Köberle, Hüdayi Korkusuz, et al.. (2015). Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma. Cancer Research. 75(15). 3147–3154. 54 indexed citations
16.
Finkelmeier, Fabian, Andrea O. Tal, Natalie Filmann, et al.. (2015). ERCP in elderly patients: increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis. Gastrointestinal Endoscopy. 82(6). 1051–1059. 57 indexed citations
17.
Köberle, Verena, Ahmed Atef Ibrahim, Christian Schmithals, et al.. (2015). Vesicle-associated microRNAs are released from blood cells on incubation of blood samples. Translational research. 169. 40–46. 15 indexed citations
18.
Kronenberger, Bernd, Ina Rudloff, Malte Bachmann, et al.. (2012). Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study. BMC Medicine. 10(1). 102–102. 41 indexed citations
19.
Wild, Philipp S., Hesso Farhan, David G. McEwan, et al.. (2011). Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth. Science. 333(6039). 228–233. 1030 indexed citations breakdown →
20.
Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2011). Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis. 19(2). e58–65. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Huang Breakdown of academic impact, for papers by Bernd Kronenberger Breakdown of academic impact, for papers by Zsuzsa Schaff Breakdown of academic impact, for papers by Ilona Kovalszky Breakdown of academic impact, for papers by Salvatore Antonaci Breakdown of academic impact, for papers by Bruno Sáinz Breakdown of academic impact, for papers by Takuya Miyagi Breakdown of academic impact, for papers by Gary Reynolds Breakdown of academic impact, for papers by Ingmar Mederacke Breakdown of academic impact, for papers by Hitoshi Asakura
Rankless by CCL
2026